Patent · US Active

Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity

US8318664B2 · kind B2 · utility

2Cited by
7References
12Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 29, 2011
Grant dateNov 27, 2012
Priority date—
Expiry dateApr 29, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/60
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating obesity and more particularly a method for treating diet-induced obesity in a subject comprising administering to said subject an isolated unacylated ghrelin peptide as set forth in SEQ ID NO: 1, a fragment thereof or a cyclic fragment thereof such as a cyclic unacylated ghrelin fragment. The method being achievable without affecting the food intake of the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.